Abstract:ABSTRACT Streptococcus pneumoniae ( Spn ) is a bacterial pathogen that causes a range of disease manifestations in children, from acute otitis media to pneumonia, septicemia, and meningitis. Primary Spn laboratory diagnostic identification methods include culture, antigen testing, single-plex real-time PCR, and syndromic PCR panels. However, each method lacks sensitivity, specificity, and/or cost efficiency. We developed and validated a quantitative, multiplex PCR assay that uses three Spn genomic targets ( lytA, piaB , and SP2020) for improved sensitivity and specificity to detect Spn in pleural fluid (PF), bronchoalveolar lavage (BAL), tracheal aspirate (TA), and upper respiratory (UR, research only) samples. Validation testing included analytical sensitivity (limit of detection), specimen storage, analytical specificity (cross-reactivity), and accuracy studies. Limit of detection is 500 genome copies/mL in lower respiratory samples and 100 copies/mL in upper respiratory specimens, with quantification range of 1,000 to 10,000,000 copies/mL. Specimens can be stored frozen at least 60 days and Spn DNA is stable through three freeze-thaw cycles. No cross-reactivity was observed against 20 closely related microorganisms and/or microorganisms that can be detected in similar sample types, including Streptococcus pseudopneumoniae . In reference range testing, Spn was detected in 5 of 23 (21.7%) PF, 2 of 19 (10.5%) BAL, 1 of 20 (5.0%) TA, and 44 of 178 (24.7%) UR residual specimens. For accuracy studies, 98 specimens were tested and overall percent agreement with a qualitative, lytA -based comparator assay was 96.9% across all sample types. This multiplex, quantitative PCR assay is a sensitive and specific method for Spn detection in pediatric respiratory samples. IMPORTANCE Streptococcus pneumoniae ( Spn ) is the world’s leading cause of lower respiratory tract infection morbidity and mortality in children. However, current clinical microbiological methods have disadvantages. Spn is difficult to grow in laboratory conditions, especially if a patient is pretreated; Spn antigen testing has unclear clinical utility in children; and syndromic panel testing is cost ineffective and entails a full, expensive validation if used for multiple respiratory sources. Therefore, better diagnostic modalities are needed. Our study validates a multiplex PCR assay with three genomic targets for semi-quantitative and quantitative Spn molecular detection from lower respiratory sources for clinical testing and from upper respiratory sources for research investigation.

PCR-Based Serotyping of Streptococcus pneumoniae from Culture-Negative Specimens: Novel Primers for Detection of Serotypes within Serogroup 18

Enhanced detection and serotyping of Streptococcus pneumoniae using multiplex polymerase chain reaction

Simultaneous Detection of Key Bacterial Pathogens Related to Pneumonia and Meningitis Using Multiplex PCR Coupled with Mass Spectrometry.

Serotyping Streptococcus pneumoniae by Multiplex PCR

A specific polymerase chain reaction test for the identification of Streptococcus pneumoniae

Optimization of a high-throughput nanofluidic real-time PCR to detect and quantify of 15 bacterial species and 92 Streptococcus pneumoniae serotypes

Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples

Serological and Molecular Capsular Typing, Antibiotic Susceptibility and Multilocus Sequence Typing of Streptococcus Pneumoniae Isolates from Invasive and Non-Invasive Infections.

Detection of Pseudomonas Aeruginosa Serogroup G Using Real-Time PCR for Novel Target Genes Identified Through Comparative Genomics.

Triplex Direct Quantitative Polymerase Chain Reaction for the Identification of Streptococcus pneumoniae Serotypes

Comparison of four polymerase chain reaction assays for specificity in the identification of Streptococcus pneumoniae

Development of a polymerase chain reaction assay to detect the presence of Streptococcus pneumoniae DNA

Establishment of a Multiplex PCR Assay for Detection of SS-2,APP and PM

Development and validation of a multiplex real-time PCR assay for detection and quantification of Streptococcus pneumoniae in pediatric respiratory samples

Streptococcus pneumoniae Type Determination by Multiplex Polymerase Chain Reaction

Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia

Development of Multiplex RT-PCR with Immobilized Primers for Identification of Infectious Human Pneumonia Pathogens

Identification of Actinobacillus actinomycetemcomitans serotypes by polymerase chain reaction

Identification of a patient withStreptococcus pneumoniaebacteremia and meningitis by the polymerase chain reaction (PCR)

[Development of Multiplex RT-PCR with Immobilized Primers for Identification of Infectious Human Pneumonia Pathogens]

Detection of Streptococcus pneumoniae in sputum samples by PCR